SOD1 Polyclonal Antibody

The protein encoded by this gene binds copper and zinc ions and is one of two isozymes responsible for destroying free superoxide radicals in the body. The encoded isozyme is a soluble cytoplasmic protein, acting as a homodimer to convert naturally-occuring but harmful superoxide radicals to molecular oxygen and hydrogen peroxide. The other isozyme is a mitochondrial protein. Mutations in this gene have been implicated as causes of familial amyotrophic lateral sclerosis. Rare transcript variants have been reported for this gene.

Introducing the SOD1 Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate advanced research in the field of neurodegenerative diseases. This meticulously crafted antibody is specifically engineered to target and detect the superoxide dismutase 1 (SOD1) protein, a key player in oxidative stress regulation.

With its high specificity and sensitivity, the SOD1 Polyclonal Antibody offers researchers an invaluable resource for investigating the intricate mechanisms underlying neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). Its polyclonal nature ensures a broad recognition of various epitopes, enhancing the versatility and reliability of experimental results.

Crafted with utmost precision, this antibody undergoes rigorous quality control measures to guarantee optimal performance and reproducibility. Its exceptional affinity for SOD1 enables accurate detection and quantification, enabling researchers to delve deeper into the intricate pathways associated with oxidative stress and neurodegeneration.

The SOD1 Polyclonal Antibody is compatible with a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse experimental setups, empowering researchers to explore SOD1's role in disease progression and therapeutic interventions.

Furthermore, this antibody is manufactured using state-of-the-art techniques and adheres to the highest industry standards. Its formulation ensures long-term stability, enabling researchers to confidently store and utilize this antibody for extended periods without compromising its efficacy.

In summary, the SOD1 Polyclonal Antibody represents a breakthrough in neurodegenerative disease research, offering scientists an indispensable tool to unravel the complexities of SOD1 and its implications in various pathological conditions. With its exceptional specificity, versatility, and reliability, this antibody is poised to revolutionize the field and contribute to the advancement of therapeutic strategies targeting neurodegenerative disorders.